Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Retained Earnings: 2022-2024

Historic Retained Earnings for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to -$795.8 million.

  • Immunocore Holdings' Retained Earnings fell 3.79% to -$801.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$801.2 million, marking a year-over-year decrease of 3.79%. This contributed to the annual value of -$795.8 million for FY2024, which is 6.86% down from last year.
  • As of FY2024, Immunocore Holdings' Retained Earnings stood at -$795.8 million, which was down 6.86% from -$744.7 million recorded in FY2023.
  • Immunocore Holdings' Retained Earnings' 5-year high stood at -$689.4 million during FY2022, with a 5-year trough of -$795.8 million in FY2024.
  • Moreover, its 3-year median value for Retained Earnings was -$744.7 million (2023), whereas its average is -$743.3 million.
  • Data for Immunocore Holdings' Retained Earnings shows a maximum YoY declined of 8.02% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Immunocore Holdings' Retained Earnings stood at -$689.4 million in 2022, then decreased by 8.02% to -$744.7 million in 2023, then fell by 6.86% to -$795.8 million in 2024.